Edition:
United States

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

38.35USD
16 Feb 2018
Change (% chg)

$-0.80 (-2.04%)
Prev Close
$39.15
Open
$39.20
Day's High
$39.65
Day's Low
$37.85
Volume
142,498
Avg. Vol
177,846
52-wk High
$50.03
52-wk Low
$24.65

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.27 December 19 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 3 3 2
(2) OUTPERFORM 4 4 4 4
(3) HOLD 1 1 1 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.75 1.75 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 3 87.68 91.12 84.62 --
Quarter Ending Jun-18 3 97.51 99.54 94.80 --
Year Ending Dec-18 8 389.29 405.00 360.00 358.98
Earnings (per share)
Quarter Ending Mar-18 4 0.27 0.35 0.21 --
Quarter Ending Jun-18 4 0.39 0.47 0.36 --
Year Ending Dec-18 8 1.58 1.85 1.25 1.77
LT Growth Rate (%) 1 26.00 26.00 26.00 38.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 79.16 80.40 1.24 1.57
Quarter Ending Jun-17 68.31 75.83 7.52 11.01
Quarter Ending Mar-17 59.07 57.58 1.49 2.53
Quarter Ending Dec-16 58.83 62.37 3.54 6.02
Quarter Ending Sep-16 56.19 56.81 0.62 1.11
Earnings (per share)
Quarter Ending Sep-17 0.27 0.29 0.02 6.42
Quarter Ending Jun-17 0.24 0.32 0.08 33.33
Quarter Ending Mar-17 0.22 0.19 0.03 12.84
Quarter Ending Dec-16 0.25 0.26 0.01 4.00
Quarter Ending Sep-16 0.34 0.37 0.03 8.28

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 87.68 87.68 85.96 85.96 --
Quarter Ending Jun-18 97.51 97.51 98.87 98.87 --
Year Ending Dec-18 389.29 389.29 388.97 388.97 358.98
Earnings (per share)
Quarter Ending Mar-18 0.27 0.27 0.24 0.23 --
Quarter Ending Jun-18 0.39 0.39 0.40 0.37 --
Year Ending Dec-18 1.58 1.58 1.56 1.49 1.77

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 1 0
Earnings
Quarter Ending Mar-18 0 0 0 0
Quarter Ending Jun-18 0 0 0 0
Year Ending Dec-18 0 0 1 0